Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2

Journal of Biological Chemistry

Volumn 289, Issue 17, 2014, Pages 11807-11815

  Jing, Gu ^a   Westwell Roper, Clara ^b   Chen, Junqin ^a   Xu, Guanlan ^a   Verchere, C Bruce ^b   Shalev, Anath ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; GLYCOPROTEINS; PIGMENTS; SIGNALING;

BETA CELL; ISLET AMYLOID POLYPEPTIDES; MEDIATED TRANSCRIPTION; SIGNALING PATHWAYS; TRANSCRIPTIONAL REGULATION;

PROTEINS;

AMYLIN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3BETA; MICRORNA 124; MICRORNA 124A; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; HUMAN; KNOCKOUT MOUSE; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BETA CELL; DIABETES; ISLET AMYLOID POLYPEPTIDE; MICRORNA; THIOREDOXIN; THIOREDOXIN-INTERACTING PROTEIN; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; DOWN-REGULATION; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; ISLET AMYLOID POLYPEPTIDE; MICE; MICE, KNOCKOUT; MICRORNAS; RATS; THIOREDOXINS; TRANSCRIPTION, GENETIC;

EID: 84899418141     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.525022     Document Type: Article

References (44)

1. Rivera, J. F., Gurlo, T., Daval, M., Huang, C. J., Matveyenko, A. V., Butler, P. C., and Costes, S. (2011) Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic beta-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death Differ. 18, 415-426
2. Westermark, P., Andersson, A., and Westermark, G. T. (2011) Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795-826
3. 2+ concentration, and insulin secretion. Diabetes Metab. Res. Rev. 27, 28-34
4. Haataja, L., Gurlo, T., Huang, C. J., and Butler, P. C. (2008) Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 29, 303-316 (Pubitemid 351679701)
5. Janson, J., Ashley, R. H., Harrison, D., McIntyre, S., and Butler, P. C. (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491-498 (Pubitemid 29106861)
6. Shalev, A., Pise-Masison, C. A., Radonovich, M., Hoffmann, S. C., Hirshberg, B., Brady, J. N., and Harlan, D. M. (2002) Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFβ signaling pathway. Endocrinology 143, 3695-3698 (Pubitemid 34925747)
7. Cha-Molstad, H., Saxena, G., Chen, J., and Shalev, A. (2009) Glucosestimulated expression of Txnip is mediated by carbohydrate response element- binding protein, p300, and histone H4 acetylation in pancreatic β cells. J. Biol. Chem. 284, 16898-16905
8. Minn, A. H., Hafele, C., and Shalev, A. (2005) Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces β-cell apoptosis. Endocrinology 146, 2397-2405 (Pubitemid 40577527)
9. Chen, J., Saxena, G., Mungrue, I. N., Lusis, A. J., and Shalev, A. (2008) Thioredoxin-interacting protein: a critical link between glucose toxicity and β-cell apoptosis. Diabetes 57, 938-944
10. Chen, J., Hui, S. T., Couto, F. M., Mungrue, I. N., Davis, D. B., Attie, A. D., Lusis, A. J., Davis, R. A., and Shalev, A. (2008) Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic β-cell mass and protects against diabetes. FASEB J. 22, 3581-3594
11. Yoshioka, J., Schulze, P. C., Cupesi, M., Sylvan, J. D., MacGillivray, C., Gannon, J., Huang, H., and Lee, R. T. (2004) Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 109, 2581-2586 (Pubitemid 38720560)
12. Oslowski, C. M., Hara, T., O'Sullivan-Murphy, B., Kanekura, K., Lu, S., Hara, M., Ishigaki, S., Zhu, L. J., Hayashi, E., Hui, S. T., Greiner, D., Kaufman, R. J., Bortell, R., and Urano, F. (2012) Thioredoxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. Cell Metab. 16, 265-273
13. Minn, A. H., Pise-Masison, C. A., Radonovich, M., Brady, J. N., Wang, P., Kendziorski, C., and Shalev, A. (2005) Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein. Biochem. Biophys. Res. Commun. 336, 770-778 (Pubitemid 41338335)
14. Xu, G., Chen, J., Jing, G., and Shalev, A. (2013) Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nat. Med. 19, 1141-1146
15. Sun, Y., Koo, S., White, N., Peralta, E., Esau, C., Dean, N. M., and Perera, R. J. (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 32, e188
16. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., Lin, C., Socci, N. D., Hermida, L., Fulci, V., Chiaretti, S., Foà, R., Schliwka, J., Fuchs, U., Novosel, A., Müller, R. U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D. B., Choksi, R., De Vita, G., Frezzetti, D., Trompeter, H. I., Hornung, V., Teng, G., Hartmann, G., Palkovits, M., Di Lauro, R., Wernet, P., Macino, G., Rogler, C. E., Nagle, J. W., Ju, J., Papavasiliou, F. N., Benzing, T., Lichter, P., Tam, W., Brownstein, M. J., Bosio, A., Borkhardt, A., Russo, J. J., Sander, C., Zavolan, M., and Tuschl, T. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414 (Pubitemid 46970709)
17. Winter, J., Jung, S., Keller, S., Gregory, R. I., and Diederichs, S. (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228-234
18. Gasa, R., Gomis, R., Casamitjana, R., and Novials, A. (1997) Signals related to glucose metabolism regulate islet amyloid polypeptide (IAPP) gene expression in human pancreatic islets. Regul. Pept. 68, 99-104 (Pubitemid 27138363)
19. Watada, H., Kajimoto, Y., Kaneto, H., Matsuoka, T., Fujitani, Y., Miyazaki Ji, and Yamasaki, Y. (1996) Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem. Biophys. Res. Commun. 229, 746-751
20. Mulder, H., Ahrén, B., and Sundler, F. (1996) Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats. Am. J. Physiol. 271, E1008-1014
21. Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner- Weir, S., Baskin, D. G., and Kahn, S. E. (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic β cell expression of human islet amyloid polypeptide. Proc. Natl. Acad. Sci. U.S.A. 93, 3492-3496
22. Minn, A. H., Lan, H., Rabaglia, M. E., Harlan, D. M., Peculis, B. A., Attie, A. D., and Shalev, A. (2005) Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance. Mol. Endocrinol. 19, 794-803 (Pubitemid 40349449)
23. Xu, G., Chen, J., Jing, G., and Shalev, A. (2012) Preventing β-cell loss and diabetes with calcium channel blockers. Diabetes 61, 848-856
24. Saxena, G., Chen, J., and Shalev, A. (2010) Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J. Biol. Chem. 285, 3997-4005
25. Shepherd, L. M., Campbell, S. C., and Macfarlane, W. M. (2004) Transcriptional regulation of the IAPP gene in pancreatic beta-cells. Biochim. Biophys. Acta 1681, 28-37 (Pubitemid 39550368)
26. Macfarlane, W. M., Campbell, S. C., Elrick, L. J., Oates, V., Bermano, G., Lindley, K. J., Aynsley-Green, A., Dunne, M. J., James, R. F., and Docherty, K. (2000) Glucose regulates islet amyloid polypeptide gene transcription in a PDX1- and calcium-dependent manner. J. Biol. Chem. 275, 15330-15335 (Pubitemid 30337260)
27. Wang, M., and Drucker, D. J. (1996) Activation of amylin gene transcription by LIM domain homeobox gene isl-1. Mol. Endocrinol. 10, 243-251 (Pubitemid 26082696)
28. Gao, N., LeLay, J., Vatamaniuk, M. Z., Rieck, S., Friedman, J. R., and Kaestner, K. H. (2008) Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev. 22, 3435-3448
29. Chen, F., Zhu, Y., Tang, X., Sun, Y., Jia, W., Sun, Y., and Han, X. (2011) Dynamic regulation of PDX-1 and FoxO1 expression by FoxA2 in dexamethasone- induced pancreatic beta-cells dysfunction. Endocrinology 152, 1779-1788
30. Baroukh, N., Ravier, M. A., Loder, M. K., Hill, E. V., Bounacer, A., Scharfmann, R., Rutter, G. A., and Van Obberghen, E. (2007) MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic βcell lines. J. Biol. Chem. 282, 19575-19588 (Pubitemid 47100119)
31. Huang, C. J., Lin, C. Y., Haataja, L., Gurlo, T., Butler, A. E., Rizza, R. A., and Butler, P. C. (2007) High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56, 2016-2027 (Pubitemid 47201819)
32. Tokuyama, T., Yagui, K., Yamaguchi, T., Huang, C. I., Kuramoto, N., Shimada, F., Miyazaki, J., Horie, H., Saito, Y., Makino, H., and Kanatsuka, A. (1997) Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic β cells. Metabolism 46, 1044-1051 (Pubitemid 27371822)
33. Marzban, L., Tomas, A., Becker, T. C., Rosenberg, L., Oberholzer, J., Fraser, P. E., Halban, P. A., and Verchere, C. B. (2008) Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture. Diabetes 57, 3045-3055
34. Ogihara, T., Vanderford, N. L., Maier, B., Stein, R. W., and Mirmira, R. G. (2009) Expression and function of Set7/9 in pancreatic islets. Islets 1, 269-272
35. Kameswaran, V., Bramswig, N. C., McKenna, L. B., Penn, M., Schug, J., Hand, N. J., Chen, Y., Choi, I., Vourekas, A., Won, K. J., Liu, C., Vivek, K., Naji, A., Friedman, J. R., and Kaestner, K. H. (2014) Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 19, 135-145
36. Lantz, K. A., Vatamaniuk, M. Z., Brestelli, J. E., Friedman, J. R., Matschinsky, F. M., and Kaestner, K. H. (2004) Foxa2 regulates multiple pathways of insulin secretion. J. Clin. Invest. 114, 512-520 (Pubitemid 39572101)
37. Gao, N., Le Lay, J., Qin, W., Doliba, N., Schug, J., Fox, A. J., Smirnova, O., Matschinsky, F. M., and Kaestner, K. H. (2010) Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell. Mol. Endocrinol. 24, 1594-1604
38. Friedman, J. R., and Kaestner, K. H. (2006) The Foxa family of transcription factors in development and metabolism. Cell Mol. Life Sci. 63, 2317-2328 (Pubitemid 44653042)
39. Sund, N. J., Vatamaniuk, M. Z., Casey, M., Ang, S. L., Magnuson, M. A., Stoffers, D. A., Matschinsky, F. M., and Kaestner, K. H. (2001) Tissuespecific deletion of Foxa2 in pancreatic β cells results in hyperinsulinemic hypoglycemia. Genes Dev. 15, 1706-1715 (Pubitemid 32702591)
40. Wolfrum, C., and Stoffel, M. (2006) Coactivation of Foxa2 through Pgc- 1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 3, 99-110
41. Zhang, L., Rubins, N. E., Ahima, R. S., Greenbaum, L. E., and Kaestner, K. H. (2005) Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab. 2, 141-148
42. Westwell-Roper, C., Dai, D. L., Soukhatcheva, G., Potter, K. J., van Rooijen, N., Ehses, J. A., and Verchere, C. B. (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J. Immunol. 187, 2755-2765
43. Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., Mullooly, N., Mielke, L. A., Harris, J., Coll, R. C., Mills, K. H., Mok, K. H., Newsholme, P., Nuñez, G., Yodoi, J., Kahn, S. E., Lavelle, E. C., and O'Neill, L. A. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 in type 2 diabetes. Nat. Immunol. 11, 897-904
44. Alarcon, C., Verchere, C. B., and Rhodes, C. J. (2012) Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets. Endocrinology 153, 2082-2087